ROM Outcomes in Patients Undergoing a Primary TKA

September 14, 2021 updated by: Arthur Malkani, University of Louisville

Will Visual Affirmation of Knee Range of Motion (ROM) Affect Patient Outcomes in Patients Undergoing a Primary Total Knee Arthroplasty (TKA)? A Prospective, Randomized Study.

The goal of this prospective, randomized study is to compare the outcomes of patients undergoing primary TKA after photographing final knee range of motion immediately post-operatively and sharing these photographs with patients at their first follow-up appointment versus a group that does not see a photograph.

Study Overview

Detailed Description

The goal of this prospective, randomized study is to compare the outcomes of patients undergoing primary total knee arthroplasty (TKA) after photographing final knee range of motion immediately postoperatively and sharing these photographs with patients at their first follow-up appointment versus a group that does not see a photograph. The knee will be photographed in maximum flexion and extension. The primary objectives will be to compare the range of motion of the operative knee at 2 weeks and 6 weeks postoperatively. In the investigator's institution, patients who have failed to achieve 90 degrees of flexion at a postoperative period of 6 weeks undergo manipulation of the knee under anesthesia (MUA). The investigators will also measure how many patients require MUA in the photograph group and non-photograph group. MUA will be performed if patients fail to achieve 90 degrees of flexion at 6 weeks post-op.

Study Type

Interventional

Enrollment (Actual)

158

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Louisville, Kentucky, United States, 40202
        • Jewish Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years to 89 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient is between the age of 22-89
  2. Patient is scheduled to undergo a unilateral, cementless primary TKA, secondary to osteoarthritis
  3. Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization documents
  4. Patient is able to read and speak English.

Exclusion Criteria:

  1. Patient is under the age of 22 or over the age of 89
  2. Patient has preoperative stiffness/contracture of the knee secondary to post-traumatic arthritis
  3. Patient is scheduled to undergo a bilateral TKA surgery
  4. Patient is unable to read and speak English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A - will be shown their photograph at 2 weeks post-operative.
40-50 arms: patients undergoing a unilateral, cementless primary TKA, secondary to osteoarthritis will be shown a photograph of their knee, photographed in maximum flexion and extension, at 2 weeks postoperatively.
Patients who undergo primary TKA surgery will then be shown a photograph of their knee at 2 weeks postoperative.
Active Comparator: B - will not be shown their photograph
40-50 arms: patients undergoing a unilateral, cementless primary TKA, secondary to osteoarthritis will not be shown a photograph of their knee, photographed in maximum flexion and extension, at 2 weeks postoperatively.
Patients who undergo primary TKA surgery will not be shown a photograph of their knee at 2 weeks postoperative.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Society Score
Time Frame: outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)
Knee Society Score. The score is on a scale from 0-100. A higher value represents a better outcome.
outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)
Knee Society Score
Time Frame: outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
Knee Society Score. The score is on a scale from 0-100. A higher value represents a better outcome.
outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
Active range-of-motion (ROM)
Time Frame: outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)
Active ROM (range-of-motion) as measured by a goniometer (range of 0-135 degrees)
outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)
Active range-of-motion (ROM)
Time Frame: outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
Active ROM (range-of-motion) as measured by a goniometer (range of 0-135 degrees)
outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
total length of hospital stay
Time Frame: outcome measure will be taken at 2 weeks postoperatively
total length of hospital stay as defined by number of days from date of surgery to date of discharge
outcome measure will be taken at 2 weeks postoperatively
Operative Time
Time Frame: outcome measure will be taken at 2 weeks postoperatively
Total Operative Time as defined in minutes
outcome measure will be taken at 2 weeks postoperatively
Estimated Blood Loss (EBL)
Time Frame: outcome measure will be taken at 2 weeks postoperatively
Estimated Blood Loss as defined by the amount of intraoperative blood loss measured in cubic centimeters (cc).
outcome measure will be taken at 2 weeks postoperatively
WOMAC Score
Time Frame: outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)
WOMAC score. The score is on a scale from 0-100. In contrast to the Knee Society Score, on the WOMAC a lower value represents a better outcome
outcome measure will be taken preoperatively (4-6 weeks prior to date of surgery)
WOMAC Score
Time Frame: outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
WOMAC score. The score is on a scale from 0-100. In contrast to the Knee Society Score, on the WOMAC a lower value represents a better outcome
outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
Incidence of loss of knee motion requiring an MUA (manipulation under anesthesia)
Time Frame: outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
Loss of knee motion is defined as failure to achieve greater than 100 degrees of active flexion. Manipulation under anesthesia is an outpatient procedure performed by orthopedic surgeon to help improve patient's range-of-motion.
outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
Tourniquet time
Time Frame: outcome measure will be taken at 2 weeks postoperatively
Total Tourniquet Time is the number of minutes that the tourniquet is inflated, as defined in minutes.
outcome measure will be taken at 2 weeks postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with postoperative complications
Time Frame: outcome measure will be taken 6 weeks (± 2 weeks) postoperatively
Number of Participants with postoperative complications. A postoperative complication is defined as any diagnosis or condition that necessitates a re-operation or procedure on the surgical knee
outcome measure will be taken 6 weeks (± 2 weeks) postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2020

Primary Completion (Actual)

September 21, 2020

Study Completion (Actual)

May 31, 2021

Study Registration Dates

First Submitted

December 30, 2019

First Submitted That Met QC Criteria

December 30, 2019

First Posted (Actual)

January 3, 2020

Study Record Updates

Last Update Posted (Actual)

September 16, 2021

Last Update Submitted That Met QC Criteria

September 14, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 19.1179

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Patient will be shown a photograph of their knee at 2 weeks postop

3
Subscribe